Overview of Private Capital Markets for Cannabis Companies (2016‑2017)
Overview of Private Capital Markets for Cannabis Companies (2016‑2017) The passage provides a generic industry summary with no specific actors, transactions, dates beyond a broad range, or actionable leads. It lacks novel or controversial details and does not implicate high‑ranking officials or power centers. Key insights: Cannabis startups rely on friends/family, angel investors, family offices, and few dedicated funds.; Traditional venture capital and private equity remain largely absent due to legal constraints.; Capital raised in 2016‑2017 is fragmented, with small transaction sizes and limited reporting.
Summary
Overview of Private Capital Markets for Cannabis Companies (2016‑2017) The passage provides a generic industry summary with no specific actors, transactions, dates beyond a broad range, or actionable leads. It lacks novel or controversial details and does not implicate high‑ranking officials or power centers. Key insights: Cannabis startups rely on friends/family, angel investors, family offices, and few dedicated funds.; Traditional venture capital and private equity remain largely absent due to legal constraints.; Capital raised in 2016‑2017 is fragmented, with small transaction sizes and limited reporting.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.